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Relationship between frontal lobe function and antidepressant treatment in bipolar disorder and major depressive disorder: a near-infrared spectroscopy study Abstract Objective: Distinguishing depressive state of bipolar disorder from major depressive disorder on the patient's initial visit is difficult. Therefore, most patients receive antidepressant treatment at first. In this study, in order to differentiate frontal lobe dysfunction in major depression and bipolar disorder, we investigated the frontal lobe function of patients with a depressive state using near-infrared spectroscopy (NIRS) along with the dosage of antidepressants used. Methods: Thirty patients with a depressive state were evaluated using the Hamilton Rating Scale for Depression (HRS-D). Their clinical diagnosis was either bipolar disorder (n=8) or major depressive disorder (n=22). For all patients, in addition to their antidepressant dosages, the changes of oxy-hemoglobin (oxy-Hb) in the prefrontal area while they were engaged in a word-fluency task were determined using NIRS. This study was approved by the Ethics Committee of Showa University. After the purpose of the study was fully explained, written informed consent was obtained from each patient. Results: Patients with major depressive disorder showed increase of oxy-Hb in the bilateral cortices during the wordfluency task. Patients with bipolar disorder showed a higher increase of oxy-Hb in the medial frontal area than in the bilateral areas. Between patients with bipolar and unipolar depression, there were no significant differences in the HRS-D, dose of antidepressants, scores on the word fluency task, and the level of oxy-Hb. Conclusion: Our results showed that the pattern of oxy-Hb increase in patients with bipolar disorder and in those with major depressive disorder is dissociable. In addition, we demonstrated the clinical usefulness of NIRS for proper diagnosis of depression. Thus, NIRS may be useful to distinguish bipolar disorder from major depressive disorder. NIRS measurements may also be useful for assessing apparently depressive patients and the treatment efficacy of pharmacotherapy.
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A study of hippocampal volumes in first-episode, drug-naïve major depression disorder. Abstract Objective: There are many studies examined brain structural changes in the hippocampus of major depressive disorder (MDD). However, only a few studies have focused on the results of hippocampal volumes and clinical severity of depressive symptoms. The hypothesis of this study was that if there is an association between hippocampal volume and clinical severity of depressive symptoms. Method: Forty-five patients with first-episode, drug-naïve MDD and 45 healthy controls with age-and gender-matched were recruited. All participants examined with 1.5T high-resolution magnetic resonance imaging. Longitudinal axis and subfields of hippocampus was analyzed by manual method and FreeSurfer, respectively. In addition, statistical parametric mapping (SPM) was used to identify associated volumetric changes. Analysis of covariance and partial correlation was used to compare the different volumes between MDD and HCs and their association of clinical severity of depressive symptoms, which was measured by using Montgomery Åsberg Depression Rating Scale. Results: The total hippocampal volume was significantly reduced in MDD compared with HCs (F=9.186, p=0.000). In the analysis of longitudinal axis, the hippocampal head (F=5.558, p=0.001) and body (F=4.643, p=0.002), but not tail (F=0.227,
